Harbour BioMed (Guangzhou) Co. Ltd.
Harbour BioMed (Guangzhou) Co. Ltd.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HBM4003 Combine With Toripalimab in Patients With Advanced NEN and Other Solid Tumors Study | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, colorectal carcinoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2025-04-27 | NCT05167071 |